Wesana Health Holdings Inc. (WSNAF)
OTC PINK OTC PINK Primary Summary
WSNAF Chart
Wesana Health Announces Change to The Board of Directors
Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - January 24, 2025) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTC Pink: WSNAF) (the "Company") is pleased to announce the appointment of Mark Monaghan and Brendan Purdy to its board of directors. Mr. Monaghan has over 32 years of experience as an advisor, founder, and board member of investment banks and merchant banks.
Wesana Health Holdings Inc. (WSNAF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Wesana Health Holdings Inc. ever had a stock split?
Wesana Health Holdings Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Daniel Carcillo CEO | OTC PINK Exchange | CA95081C1059 ISIN |
| US Country | 7 Employees | - Last Dividend | 10 May 2021 Last Split | - IPO Date |
Overview
Wesana Health Holdings Inc., based in Chicago, Illinois, is a company currently not engaged in significant operations. Previously, the company focused on developing evidence-based formulations and protocols aimed at helping patients overcome a variety of neurological, psychological, and mental health issues stemming from trauma. However, the description indicates a pivot away from these activities, leaving the company's current operational status and future direction open-ended.
Products and Services
Previously, Wesana Health was involved in the development of several key offerings aimed at addressing trauma-related ailments:
- Evidence-Based Formulations: Wesana Health was working on the creation of medically and scientifically supported formulations. These products were designed to target and alleviate symptoms associated with neurological and psychological conditions. The objective was to base these treatments on rigorous research to ensure their efficacy and safety for patients.
- Protocols for Patient Empowerment: Alongside its formulations, the company developed specific protocols. These were structured programs or treatment plans that guided patients on how to use the formulations effectively. The aim was to empower patients with the knowledge and resources to actively participate in their own recovery and overcome mental health, psychological, and neurological issues related to trauma.
Contact Information
